REGENERON PHARMACEUTICALS INC
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: REGENERON PHARMACEUTICALS INC, 10-Q, 2000-11-14
Next: EHRMAN WILLIAM, 13F-HR, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5


<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          49,642
<SECURITIES>                                   108,857
<RECEIVABLES>                                    9,851
<ALLOWANCES>                                         0
<INVENTORY>                                      8,181
<CURRENT-ASSETS>                               137,002
<PP&E>                                          72,281
<DEPRECIATION>                                  34,622
<TOTAL-ASSETS>                                 216,319
<CURRENT-LIABILITIES>                           12,742
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            34
<OTHER-SE>                                     190,938
<TOTAL-LIABILITY-AND-EQUITY>                   216,319
<SALES>                                              0
<TOTAL-REVENUES>                                45,827
<CGS>                                                0
<TOTAL-COSTS>                                   59,076
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 227
<INCOME-PRETAX>                                (13,476)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (13,476)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (13,476)
<EPS-BASIC>                                      (0.39)
<EPS-DILUTED>                                    (0.39)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission